Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Metabolomics and Mass Spectrometry Studies, Ovarian cancer diagnosis and treatment, Cancer, Hypoxia, and Metabolism, and Cancer-related molecular mechanisms research.
Assessing the risk of diabetes in participants with DDT DDE exposure- A systematic review and meta-analysis
Improving ovarian cancer treatment decision using a novel risk predictive tool
A novel subtype to predict prognosis and treatment response with DNA driver methylation–transcription in ovarian cancer
The Discovery of New Drug-Target Interactions for Breast Cancer Treatment
WaveICA 2.0: a novel batch effect removal method for untargeted metabolomics data without using batch information
Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics
Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial
The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol
<p>Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer</p>
An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade
Circulating lncRNA BC030099 Increases in Preeclampsia Patients
Integrative prognostic subtype discovery in high‐grade serous ovarian cancer
Platelet‐derived growth factor‐D expression mediates the effect of differentiated degree on prognosis in epithelial ovarian cancer
Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients
Upregulation of miR‐874‐3p and miR‐874‐5p inhibits epithelial ovarian cancer malignancy via SIK2
Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery
Selection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS‐based nontargeted and targeted analyses
An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
Identification of pathway‐based recurrence‐associated signatures in optimally debulked patients with serous ovarian cancer
Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review
Circulating long non‐coding <scp>RNA</scp>s <i><scp>NRON</scp></i> and <i><scp>MHRT</scp></i> as novel predictive biomarkers of heart failure
Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy
A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer
Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer
Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma
Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
Agreement Between Magnetic Resonance Imaging and Pathologic Findings in the Tumor Size Evaluation Before and After Neoadjuvant Chemotherapy Treatment
Reciprocal Changes of Circulating Long Non-Coding RNAs ZFAS1 and CDR1AS Predict Acute Myocardial Infarction
Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry